Caris Life Sciences, Inc.
USD17.88
-0.44 (-2.40%)
CEO
David Dean Halbert
IPO Date
2025-06-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$18.30
Prev. Close
$18.32
Day Low
$17.75
Day High
$18.59
52W Low
$14.19
52W High
$42.50
Market Cap
$5.05B
Volume
0.16M
| -25.3 |
| 31 Dec 2023 | FY | 29.2% | -111.5% | 15.9% | -82.7% | -0.10 | 2.55 | -20.9 |
| 31 Dec 2022 | FY | 31.0% | -124.1% | 18.8% | -44.7% | -0.16 | 3.77 | -22.2 |
| 31 Dec 2020 | FY | 62.6% | 9.4% | 3.9% | 1.1% | 2.49 | 0.67 | 18.1 |
| 31 Dec 2019 | FY | 48.1% | 7.4% | 4.5% | 1.1% | 3.03 | 1.74 | 16.3 |
| 31 Dec 2018 | FY | 49.4% | 18.2% | 11.2% | 2.6% | 3.08 | 0.52 | 7.1 |
| 31 Dec 2017 | FY | 48.6% | 20.7% | 12.8% | 3.0% | 3.02 | 0.54 | 7.5 |
| 31 Dec 2016 | FY | 46.7% | 2.0% | 1.3% | 0.3% | 3.23 | 0.82 | 90.2 |
| 31 Dec 2015 | FY | 50.4% | 10.7% | 5.8% | 1.4% | 3.11 | 0.66 | 21.7 |
| 137.6 |
| 30 Sept 2025 | Q3 | 68.0% | 11.2% | 5.1% | 2.5% | 0.89 | 9.93 | 87.7 |
| 30 Jun 2025 | Q2 | 62.7% | -39.6% | -15.9% | -7.5% | 0.93 | 9.24 | -25.0 |
| 31 Mar 2025 | Q1 | 47.2% | -84.8% | 3.9% | -35.2% | -0.16 | 1.05 | -17.4 |
| 30 Jun 2024 | Q2 | 37.5% | -66.2% | 0.0% | 0.0% | 0.00 | 0.00 | -26.9 |
| 31 Mar 2024 | Q1 | 32.4% | -137.6% | 0.0% | 0.0% | 0.00 | 0.00 | -16.1 |
| 30 Sept 2021 | Q3 | 53.6% | 50.7% | 6.4% | 1.6% | 2.82 | 0.72 | 2.4 |
| 30 Jun 2021 | Q2 | 50.0% | 44.3% | 5.0% | 1.3% | 2.41 | 0.45 | 3.2 |
| 31 Mar 2021 | Q1 | 47.8% | 44.2% | 4.9% | 1.3% | 2.52 | 0.74 | 3.4 |